BLADDER TELANGIECTASIA

This adverse event was reported 13 times

BLADDER TELANGIECTASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FLUTAMIDE 1 0.0010
1 MESNA INJECTION 6 0.0007
2 MESNA 6 0.0007
3 TRIPTORELIN PAMOATE 1 0.0004
4 TRANEXAMIC ACID 1 0.0001
5 VEMURAFENIB 1 0.0001
6 CYTARABINE 5 0.0001
7 MAGNESIUM HYDROXIDE 1 0.0001
8 SIROLIMUS 1 0.0001
9 IMATINIB MESYLATE 1 0.0000
See all drugs enriched for association with BLADDER TELANGIECTASIA